Dear Doctor Letter (Rote-Hand-Brief) on Gilenya®: new contraindications in patients with cardiac disorders
2017.11.07
Active substance: fingolimod
The company Novartis is circulating information on new contraindications in patients with cardiac disorders.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN